Company Filing History:
Years Active: 2012-2015
Title: Exploring the Innovations of Seunghee Kim-Schulze
Introduction: Seunghee Kim-Schulze, an esteemed inventor located in Tenafly, NJ, has made significant contributions to the field of biotechnology through his innovative research. Holding two patents, his work primarily focuses on polypeptides and their applications, revealing the potential for therapeutic advancements in medicine.
Latest Patents: Seunghee Kim-Schulze's latest patents pertain to ILT3 polypeptides and their various uses. The first patent introduces a water-soluble polypeptide that comprises all or a portion of the extracellular domain of ILT3, explicitly excluding the Fc portion of an immunoglobulin. The second patent outlines an alternative polypeptide that includes the extracellular domain of ILT3 operably affixed to the Fc portion of an immunoglobulin, wherein the Fc portion has been enhanced through specific mutations, making the resultant polypeptide also water-soluble. Additionally, a third polypeptide is described, which includes the extracellular domain of ILT3 affixed to a transmembrane domain. These inventions also encompass related nucleic acids, expression vectors, and methodologies for therapeutic and prophylactic applications.
Career Highlights: Seunghee Kim-Schulze is affiliated with Columbia University, a notable research institution that underscores his strong academic and scientific foundation. His role at such a prestigious university has allowed him to pursue cutting-edge research, contributing to his notable patents and the broader scientific community.
Collaborations: In his research journey, Seunghee Kim-Schulze has collaborated with talented individuals, including Nicole Suciu-Foca and Luigi Scotto. These partnerships have likely enriched his work, providing diverse insights and expertise crucial for innovation in biotechnology.
Conclusion: Seunghee Kim-Schulze exemplifies a dedicated inventor whose work on ILT3 polypeptides showcases the importance of scientific innovation in healthcare. His contributions, backed by patents and collaborations, reflect a commitment to improving therapeutic methods and the potential for significant advancements in medical research.